SLC2A1 and cancer: Alternatively, downstream inhibition of mTORC1 results in increased PKB activity through loss of a negative feedback loop, leading to increased expression of the Glucose transporter 1 (GLUT1) and 4 sugar transporters, increasing sugar uptake and facilitating cancer cell proliferation and survival [53].